Trial intelligence / Profile preview

PEPPER: Indomethacin vs Indomethacin + Lactated Ringer for PEP Prophylaxis

NCT05381428Phase 3Completed

Sponsor
Azienda USL-IRCCS di Reggio Emilia
Start
May 2022
Primary completion
Oct 2024
Countries
1
01

Overview

A Phase 3 trial of Lactated Ringer's and Dextrose Injection in acute pancreatitis (AP), sponsored by Azienda USL-IRCCS di Reggio Emilia. Started May 2022; status: completed.

02

Drugs

Lactated Ringer's and Dextrose Injection
03

Conditions

acute pancreatitis (AP)

Beyond the preview

Go deeper on NCT05381428.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05381428.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call